RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ihsan Salloum to Male

This is a "connection" page, showing publications Ihsan Salloum has written about Male.
Connection Strength

0.284
  1. Francis AN, Salloum IM. High-resolution mapping of alcohol-related brain connectivity in adults using 7T fMRI and multivoxel pattern classification. Psychiatry Res Neuroimaging. 2025 Sep; 352:112046.
    View in: PubMed
    Score: 0.060
  2. Cornelius JR, Chung T, Douaihy AB, Kirisci L, Glance J, Kmiec J, FitzGerald D, Wesesky MA, Salloum I. Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial. Psychiatry Res. 2016 Aug 30; 242:326-330.
    View in: PubMed
    Score: 0.032
  3. Cornelius JR, Douaihy A, Bukstein OG, Daley DC, Wood SD, Kelly TM, Salloum IM. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. Addict Behav. 2011 Aug; 36(8):843-8.
    View in: PubMed
    Score: 0.022
  4. Salloum IM, Douaihy A, Cornelius JR, Kirisci L, Kelly TM, Hayes J. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study. Addict Behav. 2007 Feb; 32(2):410-5.
    View in: PubMed
    Score: 0.016
  5. Douaihy AB, Stowell KR, Bui T, Daley D, Salloum I. HIV/AIDS and homelessness, Part 2: treatment issues. AIDS Read. 2005 Nov; 15(11):604-6, 611-3, 618.
    View in: PubMed
    Score: 0.015
  6. Douaihy AB, Stowell KR, Bui T, Daley D, Salloum I. HIV/AIDS and homelessness, Part 1: background and barriers to care. AIDS Read. 2005 Oct; 15(10):516-20, 527.
    View in: PubMed
    Score: 0.015
  7. Salloum IM, Cornelius JR, Douaihy A, Kirisci L, Daley DC, Kelly TM. Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study. Addict Behav. 2005 Oct; 30(9):1702-8.
    View in: PubMed
    Score: 0.015
  8. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2005 Jan; 62(1):37-45.
    View in: PubMed
    Score: 0.014
  9. Salloum IM, Douaihy A, Ndimbie OK, Kirisci L. Concurrent alcohol and cocaine dependence impact on physical health among psychiatric patients. J Addict Dis. 2004; 23(2):71-81.
    View in: PubMed
    Score: 0.013
  10. Salloum IM, Cornelius JR, Mezzich JE, Kirisci L. Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation. Bipolar Disord. 2002 Dec; 4(6):418-21.
    View in: PubMed
    Score: 0.012
  11. Falk DE, Ryan ML, Fertig JB, Devine EG, Cruz R, Brown ES, Burns H, Salloum IM, Newport DJ, Mendelson J, Galloway G, Kampman K, Brooks C, Green AI, Brunette MF, Rosenthal RN, Dunn KE, Strain EC, Ray L, Shoptaw S, Ait-Daoud Tiouririne N, Gunderson EW, Ransom J, Scott C, Leggio L, Caras S, Mason BJ, Litten RZ. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety. Alcohol Clin Exp Res. 2019 01; 43(1):158-169.
    View in: PubMed
    Score: 0.009
  12. Mar?n-Navarrete R, Medina-Mora ME, Horigian VE, Salloum IM, Villalobos-Gallegos L, Fern?ndez-Mondrag?n J. Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use. J Dual Diagn. 2016 Jul-Dec; 12(3-4):261-270.
    View in: PubMed
    Score: 0.008
  13. Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2010 Mar; 167(3):289-97.
    View in: PubMed
    Score: 0.005
  14. Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, Ciraulo D, Dackis C, Roache JD, Salloum IM, Somoza E, Urschel HC, Elkashef AM. Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 2009 Sep 01; 104(1-2):133-9.
    View in: PubMed
    Score: 0.005
  15. Copeland LA, Zeber JE, Salloum IM, Pincus HA, Fine MJ, Kilbourne AM. Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis. 2008 Jan; 196(1):16-21.
    View in: PubMed
    Score: 0.004
  16. Kilbourne AM, Salloum I, Dausey D, Cornelius JR, Conigliaro J, Xu X, Pincus HA. Quality of care for substance use disorders in patients with serious mental illness. J Subst Abuse Treat. 2006 Jan; 30(1):73-7.
    View in: PubMed
    Score: 0.004
  17. Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
    View in: PubMed
    Score: 0.004
  18. Cornelius JR, Clark DB, Bukstein OG, Kelly TM, Salloum IM, Wood DS. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study. Addict Behav. 2005 May; 30(4):807-14.
    View in: PubMed
    Score: 0.004
  19. Kilbourne AM, Cornelius JR, Han X, Haas GL, Salloum I, Conigliaro J, Pincus HA. General-medical conditions in older patients with serious mental illness. Am J Geriatr Psychiatry. 2005 Mar; 13(3):250-4.
    View in: PubMed
    Score: 0.004
  20. Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, Conigliaro J, Haas GL. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004 Oct; 6(5):368-73.
    View in: PubMed
    Score: 0.004
  21. Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol. 2004 Aug; 24(4):421-8.
    View in: PubMed
    Score: 0.003
  22. Cornelius JR, Maisto SA, Martin CS, Bukstein OG, Salloum IM, Daley DC, Wood DS, Clark DB. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav. 2004 Jul; 29(5):1035-8.
    View in: PubMed
    Score: 0.003
  23. Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Clark DB. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation. J Child Adolesc Psychopharmacol. 2004; 14(1):33-8.
    View in: PubMed
    Score: 0.003
  24. Weiss RD, Griffin ML, Mazurick C, Berkman B, Gastfriend DR, Frank A, Barber JP, Blaine J, Salloum I, Moras K. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry. 2003 Jul; 160(7):1320-5.
    View in: PubMed
    Score: 0.003
  25. Woody GE, Gallop R, Luborsky L, Blaine J, Frank A, Salloum IM, Gastfriend D, Crits-Christoph P. HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr. 2003 May 01; 33(1):82-7.
    View in: PubMed
    Score: 0.003
  26. Cornelius JR, Maisto SA, Pollock NK, Martin CS, Salloum IM, Lynch KG, Clark DB. Rapid relapse generally follows treatment for substance use disorders among adolescents. Addict Behav. 2003 Mar; 28(2):381-6.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support